Myoma Screw in Manipulation of Large Uterus in Total Laparoscopic Hysterectomy
1 other identifier
interventional
34
1 country
1
Brief Summary
To compare between myoma screw and uterine manipulator in manipulation of large uterus in total laparoscopic hysterectomy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedFirst Posted
Study publicly available on registry
May 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedMay 16, 2025
April 1, 2025
Same day
April 9, 2025
May 9, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Comparison between Magneshkar uterine manipulator and myoma screw in operation time in hours
Using myoma screw as a manipulator in total laparoscopic hysterectomy
During surgery in hours
Secondary Outcomes (1)
Volume of blood loss in ml liters
Day 1
Study Arms (2)
Myoma screw usage in total laparoscopic hysterectomy in large uterus
EXPERIMENTALUsing myoma screw from abdominal approach in manipulation Instead of traditional uterine mani Pulator
Uterine manipulator in total laparoscopic hysterectomy in large uterus
EXPERIMENTALUsing traditional uterine manipulator via vagina in uterine manipulation
Interventions
Hysterectomy by laparoscope using uterine manipulator or myoma screw as a manipulator of large uterus
Eligibility Criteria
You may qualify if:
- Age 30-60
- BMI 25-40
- Large uterus with fundal level 12-24w diagnosed by TAS( Transabdominal Ultrasound)/TVUS(Transvaginal ultrasound)
- Adenomyosis
You may not qualify if:
- BMI more than 40
- patients with contraindication for laparscopic surgery e.g cardiac and cirrhotic patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kafrelsheikh University
Kafr ash Shaykh, Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
April 9, 2025
First Posted
May 16, 2025
Study Start
May 1, 2025
Primary Completion
May 1, 2025
Study Completion
June 1, 2025
Last Updated
May 16, 2025
Record last verified: 2025-04